Total Valuation
NFL Biosciences SA has a market cap or net worth of €11.23M. The enterprise value is €9.31M.
Market Cap€11.23M
Enterprise Value€9.31M
Share Statistics
NFL Biosciences SA has 12,672,242 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,672,242
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NFL Biosciences SA’s return on equity (ROE) is -10.84 and return on invested capital (ROIC) is -374.78%.
Return on Equity (ROE)-10.84
Return on Assets (ROA)-0.91
Return on Invested Capital (ROIC)-374.78%
Return on Capital Employed (ROCE)-5.23
Revenue Per Employee0.00
Profits Per Employee-829.49K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NFL Biosciences SA is ―. NFL Biosciences SA’s PEG ratio is -0.19.
PE Ratio―
PS Ratio0.00
PB Ratio48.85
Price to Fair Value48.85
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-0.19
Income Statement
In the last 12 months, NFL Biosciences SA had revenue of 0.00 and earned -3.32M in profits. Earnings per share was -0.26.
Revenue0.00
Gross Profit-2.52M
Operating Income-3.87M
Pretax Income-3.86M
Net Income-3.32M
EBITDA-3.79M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
NFL Biosciences SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.98
52-Week Price Change-24.65%
50-Day Moving Average0.91
200-Day Moving Average1.08
Relative Strength Index (RSI)42.50
Average Volume (3m)55.03K
Important Dates
NFL Biosciences SA upcoming earnings date is Oct 27, 2026, Before Open (Confirmed).
Last Earnings DateApr 15, 2026
Next Earnings DateOct 27, 2026
Ex-Dividend Date―
Financial Position
NFL Biosciences SA as a current ratio of 1.17, with Debt / Equity ratio of 190.30%
Current Ratio1.17
Quick Ratio1.17
Debt to Market Cap0.04
Net Debt to EBITDA0.37
Interest Coverage Ratio-272.89
Taxes
In the past 12 months, NFL Biosciences SA has paid -539.78K in taxes.
Income Tax-539.78K
Effective Tax Rate0.14
Enterprise Valuation
NFL Biosciences SA EV to EBITDA ratio is -3.58, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA-3.58
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
NFL Biosciences SA has €2.20M in cash and marketable securities with €582.59K in debt, giving a net cash position of €1.62M billion.
Cash & Marketable Securities€2.20M
Total Debt€582.59K
Net Cash€1.62M
Net Cash Per Share€0.13
Tangible Book Value Per Share€0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NFL Biosciences SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-23.14%